Rainmed Medical (HKSE:02297) FCF Margin % : -496.00% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Rainmed Medical FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Rainmed Medical's Free Cash Flow for the six months ended in Dec. 2023 was HK$-123.94 Mil. Rainmed Medical's Revenue for the six months ended in Dec. 2023 was HK$24.99 Mil. Therefore, Rainmed Medical's FCF Margin % for the quarter that ended in Dec. 2023 was -496.00%.

As of today, Rainmed Medical's current FCF Yield % is -101.55%.

The historical rank and industry rank for Rainmed Medical's FCF Margin % or its related term are showing as below:

HKSE:02297' s FCF Margin % Range Over the Past 10 Years
Min: -321.33 Med: -148.36 Max: -28.93
Current: -321.33

During the past 4 years, the highest FCF Margin % of Rainmed Medical was -28.93%. The lowest was -321.33%. And the median was -148.36%.

HKSE:02297's FCF Margin % is ranked worse than
86.55% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -7.06 vs HKSE:02297: -321.33

Rainmed Medical FCF Margin % Historical Data

The historical data trend for Rainmed Medical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rainmed Medical FCF Margin % Chart

Rainmed Medical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-28.93

-128.01

-168.70

-321.33

Rainmed Medical Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial			-156.56	-110.38	-264.17	-242.12	-496.00

Competitive Comparison of Rainmed Medical's FCF Margin %

For the Medical Devices subindustry, Rainmed Medical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rainmed Medical's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rainmed Medical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Rainmed Medical's FCF Margin % falls into.

Rainmed Medical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Rainmed Medical's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-257.338	/	80.085
	=	-321.33 %

Rainmed Medical's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-123.935	/	24.987
	=	-496.00 %

Rainmed Medical FCF Margin % Related Terms

Thank you for viewing the detailed overview of Rainmed Medical's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rainmed Medical (HKSE:02297) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rainmed Medical Ltd (HKSE:02297) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 99, Jinji Lake Avenue, Building 31, Northeast District, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000

Website

https://www.rainmed.com

Rainmed Medical Ltd is focused on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microcirculatory resistance systems. The company's core products, the caFFR system and the caIMR system are innovative medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD).

Executives

Huo Yunfei	2101 Beneficial owner
Zhou Bin
Zhong Guo Ping An Bao Xian Ji Tuan Gu Fen You Xian Gong Si
Xi Zang Jing Jia Qi Ye Guan Li You Xian Ze Ren Gong Si
Shang Hai Jing Lin Gu Quan Tou Zi Guan Li You Xian Gong Si
Shang Hai Jing Wu Tou Zi Zhong Xin You Xian He Huo
Shang Hai Jing Mai Run Qi Ye Guan Li Zhong Xin You Xian He Huo
Gong Qing Cheng Jing Cheng Yu Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Gong Qing Cheng Jing Lin Jing Jia Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Jing Lin Zi Ben Guan Li You Xian Gong Si
Shen Zhen Jing Lin Jing Ying Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo
Shen Zhen Jing Hui Gu Quan Tou Zi Guan Li He Huo Qi Ye You Xian He Huo
Shang Hai Tong Xiang Hao Qian Qi Ye Guan Li He Huo Qi Ye You Xian He Huo
Xi Zang Jing Ning Qi Ye Guan Li You Xian Ze Ren Gong Si
Liu Li Rui

Rainmed Medical (HKSE:02297) Headlines

No Headlines